Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HBM7008 |
Trade Name | |
Synonyms | HBM 7008|HBM-7008 |
Drug Descriptions |
HBM7008 is a bispecific antibody targeting VTCN1 (B7-H4) and TNFRSF9 (4-1BB), which potentially results in activation of T-lymphocytes and antitumor activity (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | TNFRSF9 Antibody 32 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HBM7008 | HBM7008 | 0 | 1 |